RCM
JNP

Rotella Capital Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Rotella Capital Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,985
Closed -$68K – 646
2015
Q1 		$68K Sell
10,985
-16,300
-60% -$101K 0.06% 427
2014
Q4 		$153K Buy
+27,285
New +$159K 0.13% 180
2014
Q3 		– Sell
-13,241
Closed -$91K – 442
2014
Q2 		$91K Buy
+13,241
New +$88.6K 0.08% 236

Other funds holding JNP

JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BAMS
Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return

Rotella Capital Management's JNP Position: Q2 2015 in Review

Rotella Capital Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2015, closing a stake of 10,985 shares — an estimated $68K sold.

Rotella Capital Management first reported a position in JNP in Q2 2014 and held it in 3 quarters. The position peaked at $153K in Q4 2014. 44 funds tracked by Wall St. Rank hold JNP as of Q2 2015.

  • Rotella Capital Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Rotella Capital Management sold 10,985 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2015, an estimated $68K.
  • Rotella Capital Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Rotella Capital Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $153K in Q4 2014.
  • 44 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2015.

Based on Rotella Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.